Trusted Resources: People & Places
Online groups, photo galleries and blogs
Mass General – Lysosomal Storage Disorders Program
Developmental Neurogenetics ProgramCharles River Plaza, North Building
5th Floor, Suite 5240
Massachusetts General Hospital
185 Cambridge Street
Boston, Massachusetts, United States
Phone Web
The Lysosomal Storage Disorders Program is a national and international resource for the diagnostic evaluation of genetic neurodegenerative disorders for both pediatric and adult patients and their families.
In addition to evaluation and diagnosis, specialized care is delivered to patients and families with lysosomal storage disorders, including Fabry, Gaucher, Pompe, MPS, Mucolipidosis IV, and Neuronal Ceroid Lipofucsinoses (NCL) diseases.
Clinical care and participation in clinical research are aimed at better characterizing the phenotypic variability and natural history of these disorders and in the evaluation of therapies including enzyme replacement therapy and small molecules. Genetic counseling is also an area of expertise.
Related Content
-
Sanfilippo Syndrome (MPS III)https://www.onempsvoice.com/wp-content/u...
-
iPS-Derived Neural Stem Cells for Disease Modeling and Evaluation of Therapeutics for Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II), ...
-
Hearing Loss in MucopolysaccharidosisIntroduction: Mucopolysaccharidosis (MPS...
-
Experimental MPS 1 Therapy Shows Biomarker Activity, Improved FunctionREGENXBIO presented results from its ong...
-
Family Assistance ProgramProgram provides grants of up to $3000 f...
-
Advocacy Groups Unveil ‘Roadmap’ for Sanfilippo Research, CareA coalition of patient advocacy organiza...
-
Mucopolysaccharidoses Type I Gene TherapyMucopolysaccharidoses type I (MPS I) is ...